Parexel and TriNetX will aim to work together to develop deeper and more usable insights into healthcare data, in order to accelerate the launch of clinical research studies, for example studies into COVID-19 .
According to the companies, the integrated offering will leverage Datavant’s privacy-protecting linking technology, therefore helping to enhance clinical trials and bring new therapies to the market faster.
Source